A plan to genetically engineer a version of the dodo, a giant flightless bird that disappeared 400 years ago and became the poster child for extinction, has made some headway, ...
GPT, an Artificial intelligence copilot that guides scientists through designing and troubleshooting CRISPR gene-editing experiments. Trained on 11 years of expert data, it accelerates experiment ...
So, 2025 is looking like a pretty busy year for mergers and acquisitions in the medical technology world. It feels like ...
Researchers from MIT have incorporated several modifications to prime editing systems, making them up to 60 times more ...
Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...
The Tel Aviv-based company said the technology enhances the precision and efficiency of tools like CRISPR, accelerating the development of traits such as drought tolerance, yield improvement, and ...
PlantArcBio, an Israeli ag-biotech firm, has secured patents in the U.S. and South Korea for its DIPPER platform. This ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced it has completed enrollment in ...
CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...
A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into functional ones. However, the process carries a small chance of inserting ...
A study using CRISPR restored brain connectivity and made the brain more resilient to seizures, which are often seen in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback